These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1219 related articles for article (PubMed ID: 4536589)

  • 1. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
    Simmons RL; Rios A
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
    [No Abstract]   [Full Text] [Related]  

  • 5. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.
    Rios A; Simmons RL
    Surgery; 1974 Apr; 75(4):503-7. PubMed ID: 4840798
    [No Abstract]   [Full Text] [Related]  

  • 11. Horizons in tumor immunology. A seminar.
    Wilson RE; Alexander P; Rosenberg SA; Simmons RL
    Arch Surg; 1974 Jul; 109(1):17-29. PubMed ID: 4834133
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of immunotherapy and chemotherapy to experimental tumors in rats.
    Hosokawa M; Sendo F; Gotoda E; Kobayashi H
    Gan; 1971 Feb; 62(1):57-60. PubMed ID: 5553381
    [No Abstract]   [Full Text] [Related]  

  • 15. Immuno-therapy of methyl cholanthrene induced and spontaneous tumors in mice by use of tumor vaccine, neuraminidase and BCG.
    Gautam S; Aikat BK
    Indian J Med Res; 1976 Mar; 64(3):472-81. PubMed ID: 965048
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    J Natl Cancer Inst; 1973 Aug; 51(2):637-44. PubMed ID: 4765377
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
    Simmons RL; Rios A
    J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined use of BCG and neuraminidase in experimental tumor immunotherapy.
    Simmons RL; Rios A
    Surg Forum; 1971; 22():99-101. PubMed ID: 4941334
    [No Abstract]   [Full Text] [Related]  

  • 19. The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma.
    So SK; Song CW; Rios A; Simmons RL
    J Surg Oncol; 1977; 9(6):527-40. PubMed ID: 592852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 61.